دورية أكاديمية
Coronary artery disease, 'stable' or chronic? ; Doença arterial coronariana, “estável” ou crônica? ; Enfermedad arterial coronaria ¿”estable” o crónica?
| العنوان: | Coronary artery disease, 'stable' or chronic? ; Doença arterial coronariana, “estável” ou crônica? ; Enfermedad arterial coronaria ¿”estable” o crónica? |
|---|---|
| المؤلفون: | Serna-Trejos, Juan Santiago, Lenis-González, Juan Pablo, Bermudez-Moyano, Stefanya Geraldine |
| المصدر: | Revista Información Científica; Vol. 102 (2023); 4108 ; 1028-9933 |
| بيانات النشر: | Universidad de Ciencias Médicas de Guantánamo |
| سنة النشر: | 2023 |
| المجموعة: | Revista Información Científica (RIC - Universidad de Ciencias Médicas Guantánamo) |
| مصطلحات موضوعية: | Internal Medicine, Epidemiology, Cardiology, coronary artery disease, multidisciplinary intervention, cardiovascular medicine, Medicina Interna, Epidemiologia, Cardiologia, doença arterial coronária, intervenção multidisciplinar, medicina cardiovascular, Epidemiología, Cardiología, enfermedad arterial coronaria, intervención multidisciplinaria |
| الوصف: | Letter to the editor that highlights the importance of recognizing stable coronary artery disease, as an entity to which more prominence should be attributed given the chronic repercussions on the prognosis that developing this condition implies. ; Carta ao editor que destaca a importância do reconhecimento da doença arterial coronariana estável, como entidade à qual se deve atribuir maior destaque, dadas as repercussões crônicas no prognóstico que o desenvolvimento dessa condição implica. ; Carta al editor que resalta la importancia de reconocer la enfermedad arterial coronaria estable, como una entidad a la cual se le debe atribuir más protagonismo dada las repercusiones crónicas en el pronóstico que implican desarrollar esta condición. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf; application/xml; application/epub+zip |
| اللغة: | Spanish; Castilian English |
| العلاقة: | https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5624Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5744Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5666Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5626Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5746Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5636Test; Fox KAA, Metra M, Morais J, Atar D. The myth of ‘stable’ coronary artery disease. Nat Rev Cardiol [Internet]. 2020 [citado 20 Dic 2022]; 17(1):9-21. Disponible en: https://www.nature.com/articles/s41569-019-0233-yTest; Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al. A Prospective Natural-History Study of Coronary Atherosclerosis. N Engl J Med [Internet]. 2011 [citado 20 Dic 2022]; 364(3):226-35. DOI: https://doi.org/10.1056/nejmoa1002358Test; Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med [Internet]. 2015 [citado 20 Dic 2022]; 372(25):2387-97. DOI: https://doi.org/10.1056/nejmoa1410489Test; Katritsis DG, et al. Guía ESC 2019 sobre el tratamiento de pacientes con taquicardia supraventricular. Rev Esp Cardiol [Internet]. 2020 Jun [citado 20 Dic 2022]; 73(6):496.e1-496.e60. DOI: https://doi.org/10.1016/j.recesp.2019.12.029Test; Eisen A, Bhatt DL, Steg PG, Eagle KA, Goto S, Guo J, et al. Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J Am Heart Assoc [Internet]. 2016 [citado 20 Dic 2022]; 5(10). DOI: https://doi.org/10.1161/JAHA.116.004080Test; Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med [Internet]. 2015 [citado 20 Dic 2022]; 373(22):17-28. DOI: https://doi.org/10.1056/nejmoa1504720Test; Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med [Internet]. 2016 [citado 20 Dic 2022]; 375(4):311-22. DOI: https://doi.org/10.1056/nejmoa1603827Test; Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med [Internet]. 2016 [citado 20 Dic 2022]; 375(19):1834-1844. Disponible en: https://doi.org/10.1056/nejmoa1607141Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108Test |
| DOI: | 10.5281/zenodo.7844108 |
| الإتاحة: | https://doi.org/10.5281/zenodo.7844108Test https://doi.org/10.1056/nejmoa1002358Test https://doi.org/10.1056/nejmoa1410489Test https://doi.org/10.1016/j.recesp.2019.12.029Test https://doi.org/10.1161/JAHA.116.004080Test https://doi.org/10.1056/nejmoa1504720Test https://doi.org/10.1056/nejmoa1603827Test https://doi.org/10.1056/nejmoa1607141Test https://revinfcientifica.sld.cu/index.php/ric/article/view/4108Test |
| حقوق: | Copyright (c) 2023 Juan Santiago Serna-Trejos, Juan Pablo González-Lenis, Stefanya Geraldine Bermudez-Moyano ; http://creativecommons.org/licenses/by/4.0Test |
| رقم الانضمام: | edsbas.B875C52A |
| قاعدة البيانات: | BASE |
| DOI: | 10.5281/zenodo.7844108 |
|---|